223Ra-dichloride therapy of bone metastasis: optimization of SPECT images for quantification

被引：0
|
作者：
Nadia Benabdallah
Michela Bernardini
Marta Bianciardi
Claire de Labriolle-Vaylet
Didier Franck
Aurélie Desbrée
机构：
[1] Institute for Radiological Protection and Nuclear Safety (IRSN),Internal Dose Assessment Laboratory
[2] European Hospital George Pompidou (HEGP),Nuclear Medicine Department
[3] Massachusetts General Hospital and Harvard Medical School,Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging
[4] UPMC,Nuclear Medicine Department
[5] Univ Paris 06 Biophysics,undefined
[6] Trousseau Hospital,undefined
来源：
EJNMMI Research | / 9卷
关键词：
Bone metastasis; Ra; Radionuclide therapy; Quantitative imaging; SPECT imaging; Physical phantoms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Correlation between Bone Lesion Dosimetry and Pain Outcome in Patients (pts) with Castration-Resistant Prostate Cancer (CRPC) undergoing 223Ra-dichloride Therapy
    Follacchio, G. A.
    Frantellizzi, V.
    Pacilio, M.
    Cassano, B.
    Pani, R.
    Pellegrini, R.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S215 - S215
  • [42] Effect of [223Ra]Radium dichloride on bone health
    Krieger, K.
    Afshar-Oromieh, A.
    Rominger, A.
    Weidner, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S655 - S655
  • [43] Use Of 223Ra-dichloride In Mcrpc Patients At The Early Onset Of Castration Resistance: Is Early Introduction Useful?
    Frantellizzi, V.
    De Feo, M. S.
    Lazri, J.
    Cosma, L.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S236 - S236
  • [44] Role of tALP and ECOG Performance Status in predicting survival in mCRPC patients receiving 223Ra-dichloride
    Follacchio, G. A.
    Frantellizzi, V.
    Sollaku, S.
    De Feo, M. S.
    Monteleone, F.
    Liberatore, M.
    Farcomeni, A.
    Pacilio, M.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S792 - S792
  • [45] 223Ra-dichloride spectrometric characterization: Searching for the presence of long-lived isotopes with radiological protection implications
    Sanchez-Jimenez, J.
    Lopez-Montes, A.
    Nunez-Martnez, L.
    Villa-Abaunza, A.
    Fraile, L. M.
    Sanchez-Tembleque, V.
    Udias, J. M.
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2017, 35 : 97 - 101
  • [46] Estimation of 223 Ra in a sewage system of hospital during radiopharmaceutical therapy with 223 Ra dichloride (Xofigo®)
    Chipiga, L. A.
    Petryakova, A. V.
    Vodovatov, A. V.
    Saprykin, K. S.
    Vazhenina, D. A.
    Stanzhevskiy, A. A.
    Maystrenko, D. N.
    ONKOUROLOGIYA, 2024, 20 (03):
  • [47] Radioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride
    Ahmadzadehfar, Hojjat
    Zimbelmann, Stefanie
    Yordanova, Anna
    Fimmers, Rolf
    Kuerpig, Stefan
    Eppard, Elisabeth
    Gaertner, Florian C.
    Wei, Xiao
    Hauser, Stefan
    Essler, Markus
    ONCOTARGET, 2017, 8 (33) : 55567 - 55574
  • [48] Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma
    Braeuer, Axel
    Rahbar, Kambiz
    Konnert, Julia
    Boegemann, Martin
    Stegger, Lars
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2017, 56 (01): : 14 - 22
  • [49] Co-existing lymph node and bone metastases may be negative predictive marker of survival in patients with CRPC treated with 223Ra-dichloride
    Dizdarevic, S.
    Jessop, M.
    Begley, P.
    Robinson, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S796 - S796
  • [50] Definition of a Predictive Score to guide therapeutic management in metastatic CRPC patients eligible to 223Ra-dichloride treatment
    Follacchio, G. A.
    Frantellizzi, V.
    Pontico, M.
    De Feo, M. S.
    Monteleone, F.
    Liberatore, M.
    Farcomeni, A.
    Pacilio, M.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S792 - S792
12345